A process for preparing N-[(1R)-1-(1-naphthyl)ethyl]-3-[3-(trifluoromethyl)-phenyl]propan-1-amine hydrochloride salt of formula (I)
i.e. Cinacalcet hydrochloride and its intermediates of formulae (VII) and (VIII)
wherein Z is chloride or another pharmaceutically acceptable anionic counterion.
一种制备N-[(1R)-1-(1-
萘基)乙基]-3-[3-(三
氟甲基)苯基]丙基-1-胺盐酸盐的方法,即Cinacalcet盐酸盐,以及其中间体的公式(VII)和(VIII),其中Z为
氯或另一种药物可接受的阴离子对离子。